275 related articles for article (PubMed ID: 26951715)
21. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
[TBL] [Abstract][Full Text] [Related]
22. Contemporary salvage post prostatectomy radiotherapy: Early implementation improves biochemical control.
Kneebone A; Hruby G; Harris G; Rasiah K; Vass J; Whalley D; McCloud P; Louw S; Guo L; Eade T
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):240-247. PubMed ID: 29080287
[TBL] [Abstract][Full Text] [Related]
23. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy after radical prostatectomy: immediate or early delayed?
Bottke D; Bartkowiak D; Schrader M; Wiegel T
Strahlenther Onkol; 2012 Dec; 188(12):1096-101. PubMed ID: 23128897
[TBL] [Abstract][Full Text] [Related]
25. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
26. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.
Hervás A; Gómez-Caamaño A; Casaña M; Gómez-Iturriaga A; Pastor J; Jove J; Mengual JL; Gónzalez-San Segundo C; Muñoz J
Clin Transl Oncol; 2018 Feb; 20(2):193-200. PubMed ID: 28667448
[TBL] [Abstract][Full Text] [Related]
28. The impact of prostate-specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancer.
Bartkowiak D; Siegmann A; Böhmer D; Budach V; Wiegel T
BJU Int; 2019 Nov; 124(5):785-791. PubMed ID: 31220400
[TBL] [Abstract][Full Text] [Related]
29. Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy.
Ward JF; Zincke H; Bergstralh EJ; Slezak JM; Blute ML
J Urol; 2004 Dec; 172(6 Pt 1):2244-8. PubMed ID: 15538240
[TBL] [Abstract][Full Text] [Related]
30. Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy.
Campbell SR; Tom MC; Agrawal S; Efstathiou JA; Michalski JM; Abramowitz MC; Pollack A; Spratt DE; Hearn JWD; Stephans KL; Gao T; Li J; Tendulkar RD
Eur Urol Oncol; 2022 Jun; 5(3):304-313. PubMed ID: 34016556
[TBL] [Abstract][Full Text] [Related]
31. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736
[TBL] [Abstract][Full Text] [Related]
32. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
Briganti A; Wiegel T; Joniau S; Cozzarini C; Bianchi M; Sun M; Tombal B; Haustermans K; Budiharto T; Hinkelbein W; Di Muzio N; Karakiewicz PI; Montorsi F; Van Poppel H
Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803
[TBL] [Abstract][Full Text] [Related]
33. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
Stephenson AJ; Shariat SF; Zelefsky MJ; Kattan MW; Butler EB; Teh BS; Klein EA; Kupelian PA; Roehrborn CG; Pistenmaa DA; Pacholke HD; Liauw SL; Katz MS; Leibel SA; Scardino PT; Slawin KM
JAMA; 2004 Mar; 291(11):1325-32. PubMed ID: 15026399
[TBL] [Abstract][Full Text] [Related]
34. Salvage radiation therapy for prostate cancer patients after prostatectomy.
Mima T; Ohori M; Hirasawa Y; Mikami R; Arai A; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Tokuuye K; Ohno Y
Jpn J Clin Oncol; 2019 Mar; 49(3):281-286. PubMed ID: 30608594
[TBL] [Abstract][Full Text] [Related]
35. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
36. Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?
Tay KJ; Polascik TJ; Howard LE; Salama JK; Schulman AA; Chen Z; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
Clin Genitourin Cancer; 2019 Oct; 17(5):e930-e938. PubMed ID: 31257075
[TBL] [Abstract][Full Text] [Related]
37. Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy.
Loeb S; Roehl KA; Viprakasit DP; Catalona WJ
Eur Urol; 2008 Jul; 54(1):88-94. PubMed ID: 18400368
[TBL] [Abstract][Full Text] [Related]
38. Predictor of response to salvage radiotherapy in patients with PSA recurrence after radical prostatectomy: the usefulness of PSA doubling time.
Numata K; Azuma K; Hashine K; Sumiyoshi Y
Jpn J Clin Oncol; 2005 May; 35(5):256-9. PubMed ID: 15886268
[TBL] [Abstract][Full Text] [Related]
39. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients.
Peyromaure M; Allouch M; Eschwege F; Verpillat P; Debré B; Zerbib M
Urology; 2003 Sep; 62(3):503-7. PubMed ID: 12946755
[TBL] [Abstract][Full Text] [Related]
40. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
Stephenson AJ; Scardino PT; Kattan MW; Pisansky TM; Slawin KM; Klein EA; Anscher MS; Michalski JM; Sandler HM; Lin DW; Forman JD; Zelefsky MJ; Kestin LL; Roehrborn CG; Catton CN; DeWeese TL; Liauw SL; Valicenti RK; Kuban DA; Pollack A
J Clin Oncol; 2007 May; 25(15):2035-41. PubMed ID: 17513807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
